Annual report [Section 13 and 15(d), not S-K Item 405]

EQUITY TRANSACTIONS

v3.25.1
EQUITY TRANSACTIONS
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
EQUITY TRANSACTIONS

NOTE 13 – EQUITY TRANSACTIONS

 

2024 Equity Transactions

 

During the year ended December 31, 2024, no new common stock equity transactions have occurred.

 

During the year ended December 31, 2024, 4 million shares of preferred stock of the company were issued in exchange for a consulting agreement. These preferred shares have 15-1 voting rights compared to common shares. These preferred shares are convertible to 3.6 million common shares, only after a shareholder vote occurs to expand the authorized shares of common stock. The preferred shares were valued at $144,000, and were fully earned and expense recognized at the time of issue.

 

2023 Equity Transactions

 

During the year ended December 31, 2023, no new equity transactions have occurred.

 

Non-controlling Interest

 

The non-controlling interest presented in our condensed consolidated financial statements reflects a 46% non-controlling equity interest in PWS, and 49% non-controlling equity interest in PelleChar. Net losses attributable to non-controlling interest, as reported on our condensed consolidated statements of operations, represents the net loss of each entity attributable to the non-controlling equity interest. The non-controlling interest is reflected within stockholders’ equity on the condensed consolidated balance sheet.